Wed, July 25, 2012
Tue, July 24, 2012
Mon, July 23, 2012
Fri, July 20, 2012
Thu, July 19, 2012
Wed, July 18, 2012
[ Wed, Jul 18th 2012 ]: Market Wire
Beaufield Resumes Exploration

Matthew Harrison Maintained (BMRN) at Strong Buy with Increased Target to $52 on, Jul 23rd, 2012


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-52-on-jul-23rd-2012.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation



Matthew Harrison of Morgan Stanley, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Increased Target from $43 to $52 on, Jul 23rd, 2012.

Matthew has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Martin Auster of "UBS" Initiated at Strong Buy and Held Target at $43 on, Thursday, April 12th, 2012
  • Michelle Gilson of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $43 on, Monday, March 26th, 2012

Publication Contributing Sources